BlackRock Investment Management’s SELLAS Life Sciences SLS Stock Holding History

BlackRock Investment Management’s Portfolio SLS Stock Details SLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$70K	Buy	+24	New	+$140K	﹤0.01%	3295

Other funds holding SLS

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

BlackRock Investment Management's SLS Position: Q4 2016 in Review

BlackRock Investment Management opened a new position in SELLAS Life Sciences (SLS) in Q4 2016: 24 shares worth $70K. The stake represents ﹤0.01% of the portfolio and ranks #3295 among its holdings.

44 funds tracked by Wall St. Rank hold SLS as of Q4 2016.

BlackRock Investment Management held 24 shares of SELLAS Life Sciences worth $70K as of Q4 2016.
SELLAS Life Sciences was a new BlackRock Investment Management position in Q4 2016.
SELLAS Life Sciences made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3295 holding.
44 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.